LIFECORE BIOMEDICAL, INC. Preferred Stock, Shares Issued
LIFECORE BIOMEDICAL, INC. (LFCR) had Preferred Stock, Shares Issued of 44.07 thousand shares as of 2024-11-24, per its 10-Q filed 2025-01-02.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesIssued · last filed 2025-01-02
- 2024-11-24: Preferred Stock, Shares Issued 44.07K shares.
- 2024-08-25: Preferred Stock, Shares Issued 43.26K shares.
- 2024-05-26: Preferred Stock, Shares Issued 42.46K shares.
- 2024-02-25: Preferred Stock, Shares Issued 42.00K shares.
| Period end | Preferred Stock, Shares Issued |
|---|---|
| 2024-11-24 | 44.07K shares 10-Q · filed 2025-01-02 |
| 2024-08-25 | 43.26K shares 10-Q · filed 2024-10-04 |
| 2024-05-26 | 42.46K shares 10-Q · filed 2025-01-02 |
| 2024-02-25 | 42.00K shares 10-Q · filed 2024-08-09 |
| 2023-11-26 | 41.00K shares 10-Q · filed 2024-08-09 |
| 2023-08-27 | 40.00K shares 10-Q · filed 2024-08-09 |
| 2023-05-28 | 39.00K shares 10-Q · filed 2024-08-09 |
| 2023-02-26 | 39.00K shares 10-Q · filed 2023-06-02 |
| 2022-05-29 | 0.00 shares 10-Q · filed 2023-06-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |